These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 12539199

  • 1. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors.
    Jonnala RR, Graham JH, Terry AV, Beach JW, Young JA, Buccafusco JJ.
    Synapse; 2003 Mar 15; 47(4):262-9. PubMed ID: 12539199
    [Abstract] [Full Text] [Related]

  • 2. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR, Buccafusco JJ.
    J Neurosci Res; 2001 Nov 15; 66(4):565-72. PubMed ID: 11746376
    [Abstract] [Full Text] [Related]

  • 3. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells.
    Li XD, Buccafusco JJ.
    J Pharmacol Exp Ther; 2003 Nov 15; 307(2):670-5. PubMed ID: 12970390
    [Abstract] [Full Text] [Related]

  • 4. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R, Scali C, Comery TA, Grauer SM, Aschmi S, Bothmann H, Jow B, Kowal D, Gianfriddo M, Kelley C, Zanelli U, Ghiron C, Haydar S, Dunlop J, Terstappen GC.
    J Pharmacol Exp Ther; 2009 May 15; 329(2):459-68. PubMed ID: 19223665
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties.
    Meyer EM, Tay ET, Zoltewicz JA, Meyers C, King MA, Papke RL, De Fiebre CM.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):1026-32. PubMed ID: 9495863
    [Abstract] [Full Text] [Related]

  • 6. Strychnine, but not PMBA, inhibits neuronal nicotinic acetylcholine receptors expressed by rabbit retinal ganglion cells.
    Renna JM, Strang CE, Amthor FR, Keyser KT.
    Vis Neurosci; 2007 Mar 15; 24(4):503-11. PubMed ID: 17900376
    [Abstract] [Full Text] [Related]

  • 7. Novel analogs of choline as potential neuroprotective agents.
    Buccafusco JJ, Beach JW, Terry AV, Doad GS, Sood A, Arias E, Misawa H, Masai M, Fujii T, Kawashima K.
    J Alzheimers Dis; 2004 Dec 15; 6(6 Suppl):S85-92. PubMed ID: 15665419
    [Abstract] [Full Text] [Related]

  • 8. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP.
    J Pharmacol Exp Ther; 2003 Sep 15; 306(3):1011-20. PubMed ID: 12766255
    [Abstract] [Full Text] [Related]

  • 9. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
    Chiara DC, Trinidad JC, Wang D, Ziebell MR, Sullivan D, Cohen JB.
    Biochemistry; 2003 Jan 21; 42(2):271-83. PubMed ID: 12525154
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of alpha7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells.
    Hsu SH, Tsou TC, Chiu SJ, Chao JI.
    Toxicol Lett; 2005 Oct 15; 159(1):47-59. PubMed ID: 15961264
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.
    Wu J, Toyohara J, Tanibuchi Y, Fujita Y, Zhang J, Chen H, Matsuo M, Wang RF, Hashimoto K.
    Brain Res; 2010 Nov 11; 1360():130-7. PubMed ID: 20816767
    [Abstract] [Full Text] [Related]

  • 12. Subtype-specific inhibition of nicotinic acetylcholine receptors by choline: a regulatory pathway.
    Alkondon M, Albuquerque EX.
    J Pharmacol Exp Ther; 2006 Jul 11; 318(1):268-75. PubMed ID: 16565162
    [Abstract] [Full Text] [Related]

  • 13. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B.
    Brain Res; 2005 Apr 18; 1041(2):132-42. PubMed ID: 15829222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
    Park HJ, Lee PH, Ahn YW, Choi YJ, Lee G, Lee DY, Chung ES, Jin BK.
    Eur J Neurosci; 2007 Jul 18; 26(1):79-89. PubMed ID: 17581257
    [Abstract] [Full Text] [Related]

  • 19. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM, Terry AV.
    Neuroscience; 2005 Jul 18; 130(4):997-1012. PubMed ID: 15652996
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
    Wonnacott S, Jackman S, Swanson KL, Rapoport H, Albuquerque EX.
    J Pharmacol Exp Ther; 1991 Oct 18; 259(1):387-91. PubMed ID: 1920126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.